Expression and role of long non-coding RNA GAS5 in human carcinomas

doi:10.3760/cma.j.issn.1673-422X.2016.06.012

Abstract

Hu Yiheng, Zhang Jun. Expression and role of long non-coding RNA GAS5 in human carcinomas[J]. Journal of International Oncology, 2016, 43(6): 445-447.

［1］ Schneider C, King RM, Philipson L. Genes specifically expressed at growth arrest of mammalian cells［J］. Cell, 1988, 54(6): 787-793. ［2］ Lucafo M, De Iudicibus S, Di Silvestre A, et al. Long noncoding RNA GAS5: a novel marker involved in glucocorticoid response［J］. Curr Mol Med, 2015, 15(1): 94-99. ［3］ Tu ZQ, Li RJ, Mei JZ, et al. Downregulation of long noncoding RNA GAS5 is associated with the prognosis of hepatocellular carcinoma［J］. Int J Clin Exp Pathol, 2014, 7(7): 43034309. ［4］ Chang L, Li C, Lan T, et al. Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation and invasion in hepatocellular carcinoma by regulating vimentin［J］. Mol Med Rep, 13(2): 1541-1550. DOI: 10.3892/mmr.2015.4716. ［5］ Sun M, Jin FY, Xia R, et al. Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer［J］. BMC Cancer, 2014, 14: 319. DOI: 10.1186/1471-2407-14-319. ［6］ Liu Y, Zhao J, Zhang W, et al. LncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer［J］. Sci Rep, 2015, 5: 10159. DOI: 10.1038/srep10159. ［7］ Lu X, Fang Y, Wang Z, et al. Downregulation of gas5 increases pancreatic cancer cell proliferation by regulating CDK6［J］. Cell Tissue Res, 2013, 354(3): 891-896. DOI: 10.1007/s00441-013-1711-x. ［8］ Yin D, He X, Zhang E, et al. Long noncoding RNA GAS5 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer［J］. Med Oncol, 2014, 31(11): 253. DOI: 10.1007/s12032-014-0253-8. ［9］ Krell J, Frampton AE, Mirnezami R, et al. Growth arrestspecific transcript 5 associated snoRNA levels are related to p53 expression and DNA damage in colorectal cancer［J］. PLoS One, 2014, 9(6): e98561. DOI: 10.1371/journal.pone.0098561. ［10］ YacqubUsman K, Pickard MR, Williams GT. Reciprocal regulation of GAS5 lncRNA levels and mTOR inhibitor action in prostate cancer cells［J］. Prostate, 2015, 75(7): 693-705. DOI: 10.1002/pros.22952. ［11］ Pickard MR, MourtadaMaarabouni M, Williams GT. Long noncoding RNA GAS5 regulates apoptosis in prostate cancer cell lines［J］. Biochim Biophys Acta, 2013, 1832(10): 1613-1623. DOI: 10.1016/j.bbadis.2013.05.005. ［12］ Qiao HP, Gao WS, Huo JX, et al. Long noncoding RNA GAS5 functions as a tumor suppressor in renal cell carcinoma［J］. Asian Pac J Cancer Prev, 2013, 14(2): 1077-1082. ［13］ Liu Z, Wang W, Jiang J, et al. Downregulation of GAS5 promotes bladder cancer cell proliferation, partly by regulating CDK6［J］. PLoS One, 2013, 8(9): e73991. DOI: 10.1371/journal.pone.0073991. ［14］ Dong S, Qu X, Li W, et al. The long noncoding RNA, GAS5, enhances gefitinibinduced cell death in innate EGFR tyrosine kinase inhibitorresistant lung adenocarcinoma cells with widetype EGFR via downregulation of the IGF1R expression［J］. J Hematol Oncol, 2015, 8: 43. DOI: 10.1186/s1304501501406. ［15］ Shi X, Sun M, Liu H, et al. A critical role for the long noncoding RNA GAS5 in proliferation and apoptosis in nonsmallcell lung cancer［J］. Mol Carcinog, 2015, 54 Supp 1: E1-12. DOI: 10.1002/mc.22120. Epub2013Dec19. ［16］ MourtadaMaarabouni M, Pickard MR, Hedge VL, et al. GAS5, a nonproteincoding RNA, controls apoptosis and is downregulated in breast cancer［J］. Oncogene, 2009, 28(2): 195208. DOI: 10.1038/onc.2008.373. ［17］ Zhang Z, Zhu Z, Watabe K, et al. Negative regulation of lncRNA GAS5 by miR-21［J］. Cell Death Differ, 2013, 20(11): 1558-1568. DOI: 10.1038/cdd.2013.110. ［18］ Pickard MR, Williams GT. Regulation of apoptosis by long noncoding RNA GAS5 in breast cancer cells: implications for chemotherapy［J］. Breast Cancer Res Treat, 2014, 145(2): 359-370. DOI: 10.1007/s10549-014-2974-y. ［19］ Cao S, Liu W, Li F, et al. Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer［J］. Int J Clin Exp Pathol, 2014, 7(10): 6776-6783.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou. Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer [J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun. Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer [J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Yuan Jian, Huang Yanhua. Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer [J]. Journal of International Oncology, 2024, 51(6): 338-343.
[4]	Chen Hongjian, Zhang Suqing. Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients [J]. Journal of International Oncology, 2024, 51(6): 344-349.
[5]	Guo Zehao, Zhang Junwang. Role of PFDN and its subunits in tumorigenesis and tumor development [J]. Journal of International Oncology, 2024, 51(6): 350-353.
[6]	Zhang Baihong, Yue Hongyun. Advances in anti-tumor drugs with new mechanisms of action [J]. Journal of International Oncology, 2024, 51(6): 354-358.
[7]	Xu Fenglin, Wu Gang. Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma [J]. Journal of International Oncology, 2024, 51(6): 359-363.
[8]	Wang Ying, Liu Nan, Guo Bing. Advances of antibody-drug conjugate in the therapy of metastatic breast cancer [J]. Journal of International Oncology, 2024, 51(6): 364-369.
[9]	Zhang Rui, Chu Yanliu. Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota [J]. Journal of International Oncology, 2024, 51(6): 370-375.
[10]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu. Research progress on intestinal flora and non-surgical treatment of the colorectal cancer [J]. Journal of International Oncology, 2024, 51(6): 376-381.
[11]	Liu Jing, Liu Qin, Huang Mei. Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm [J]. Journal of International Oncology, 2024, 51(5): 267-273.
[12]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin. Study on the clinical relationship between inflammatory burden index and gastric cancer [J]. Journal of International Oncology, 2024, 51(5): 274-279.
[13]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao. Effect of cancer nodules on liver metastases after radical resection of colorectal cancer [J]. Journal of International Oncology, 2024, 51(5): 280-285.
[14]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi. Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer [J]. Journal of International Oncology, 2024, 51(5): 286-291.
[15]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying. Research progress of habitat analysis in radiomics of malignant tumors [J]. Journal of International Oncology, 2024, 51(5): 292-297.

Expression and role of long non-coding RNA GAS5 in human carcinomas

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments